BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 65%* for Small Cap Pro

1 year 40%, 2 years 50% and *3 years 65%

*Across 3 years $2158.56 only $755.50

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,021.63
0.57%
US Tech 100
20,355.20
0.45%
Dow Jones
44,860.31
0.28%
Brent Oil
72.185
-0.37%
Bitcoin
92,383.09
0.45%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Denali Therapeutics Inc (DNLI) Quote

Denali Therapeutics Inc

Denali Therapeutics Inc (DNLI)

NASDAQ
24.68
0.18
(0.73%)
Closed November 26 4:00PM
Delayed by 15 minutes
24.68
0.01
(0.04%)
After Hours: 7:34PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
24.68
Bid
24.18
Ask
28.15
Volume
1,190,947
24.175 Day's Range 24.945
14.56 52 Week Range 33.33
Market Cap
3.552B
Previous Close
24.50
Open
24.51
Last Trade
10
@
25.91
Last Trade Time
Financial Volume
$ 29,299,199
VWAP
24.6016
Average Volume (3m)
888,139
Shares Outstanding
143,921,624
Dividend Yield
-
PE Ratio
-24.45
Earnings Per Share (EPS)
-1.01
Revenue
330.53M
Net Profit
-145.22M

About Denali Therapeutics Inc

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates ... Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.denalitherapeutics.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Denali Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker DNLI. The last closing price for Denali Therapeutics was $24.50. Over the last year, Denali Therapeutics shares have traded in a share price range of $ 14.56 to $ 33.33.

Denali Therapeutics currently has 143,921,624 shares outstanding. The market capitalization of Denali Therapeutics is $3.53 billion. Denali Therapeutics has a price to earnings ratio (PE ratio) of -24.45.

Ask ADVFN Intelligence (AI)

Denali Therapeutics (DNLI) Options Flow Summary

DNLI Options Flow

Overall Flow

Bullish

Net Premium

89k

Calls / Puts

200.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

DNLI Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities

4 hours ago
Edgar (US Regulatory)

Form 8-K - Current report

November 18 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 12 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 08 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

November 07 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 06 2024
Edgar (US Regulatory)

Form 8-K - Current report

November 06 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

October 22 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

October 21 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

October 18 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.994.1789784719323.6925.7723.61117749024.42070029CS
4-2.75-10.025519504227.4333.3323.6198364226.9853821CS
120.150.61149612719124.5333.3323.6188813927.7913101CS
265.1326.240409207219.5533.3317.93100505724.6183287CS
526.4235.158817086518.2633.3314.56106934421.66519085CS
156-22.02-47.152034261246.748.4614.5681715825.51697955CS
2606.6636.958934517218.0293.9412.3972524432.20103401CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PSTXPoseida Therapeutics Inc
$ 9.38
(227.97%)
29.42M
IMGCIMG Inc
$ 1.615
(156.35%)
114.46M
IDAIT Stamp Inc
$ 0.364
(102.22%)
549.04M
PGHLPrimega Group Holdings Ltd
$ 20.95
(98.77%)
2.77M
TOYOTOYO Company Ltd
$ 5.41
(86.55%)
48.64M
ALECAlector Inc
$ 2.575
(-34.97%)
7.94M
ABVEAbove Food Ingredients Inc
$ 0.5338
(-34.42%)
1.65M
LGCLLucas GC Ltd
$ 0.7511
(-33.53%)
2.48M
ADDColor Star Technology Company Ltd
$ 4.19
(-31.87%)
204.17k
LESLLeslies Inc
$ 2.445
(-30.34%)
24.38M
IDAIT Stamp Inc
$ 0.364
(102.22%)
549.04M
ELABElevai Labs Inc
$ 0.01255
(-21.07%)
323.24M
NVDANVIDIA Corporation
$ 136.92
(0.66%)
186M
RGTIRigetti Computing Inc
$ 2.195
(-20.18%)
124.14M
IMGCIMG Inc
$ 1.615
(156.35%)
114.46M

DNLI Discussion

View Posts
Monksdream Monksdream 1 month ago
DNLI under $30
👍️0
Monksdream Monksdream 1 month ago
DNLI under $30
👍️0
Monksdream Monksdream 2 months ago
DNLI new 52/high
👍️0
conix conix 2 years ago
DNLI on Seeking Alpha

https://seekingalpha.com/article/4570210-denali-need-patient-data-to-justify-that-high-valuation
👍️0
seward seward 2 years ago
Up big, why?
👍️0
seward seward 3 years ago
Up 5 pts AH news or random bid ?
👍️0
seward seward 4 years ago
Add 55.55

Been holding for 100+, flipping small shares
👍️0
seward seward 4 years ago
More flipping.

Filled for one share at 57 this morning. If it hits 62 I can buy coffee.

hans
👍️0
seward seward 4 years ago
Good earnings, flipped some in low 60s
👍️0
seward seward 4 years ago
Adding a little on pullbacks, still looking to hold till it breaks 100 and then sone.
👍️0
seward seward 4 years ago
Best stock I’ve ever seen. Next stop 100 ?
👍️0
seward seward 4 years ago
Up up up. I suppose I should sell it some day. Maybe over 100 ?
👍️0
seward seward 4 years ago
14 may not be in the cards. I may wait for 100.

hans
👍️0
seward seward 5 years ago
Up nice today for no apparent reason.

hans
👍️0
Glider549 Glider549 6 years ago
Interesting .
Stockconsultant daut kom sent me here.
Any debt? Toxic debt?
👍️0
Golden Cross Golden Cross 6 years ago
Back to $14 then do it again!
👍️0
Golden Cross Golden Cross 6 years ago
Looking into if they have a stake in private company Blaze Bioscience and their scorpion venom..GLTA
👍️0
seward seward 6 years ago
In at 14.30, already near 17. Lucky.
👍️0
seward seward 6 years ago
"Announces Advancement and Expansion of Its LRRK2 Inhibitor Clinical Program for Parkinson’s Disease"

I bought some today

hans
👍️0

Your Recent History

NASDAQ
DNLI
Denali Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 65%* for Small Cap Pro

1 year 40%, 2 years 50% and *3 years 65%

*Across 3 years $2158.56 only $755.50